Agile Therapeutics (NASDAQ:AGRX) Earns Hold Rating from Analysts at StockNews.com

Retrieved on: 2022-12-05 14:17:30

Tags for this article:

Click the tags to see associated articles and topics

Agile Therapeutics (NASDAQ:AGRX) Earns Hold Rating from Analysts at StockNews.com. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 621,200 shares of the specialty pharmaceutical company's stock valued at $130,000 after purchasing an additional ...

Article found on: www.etfdailynews.com

View Original Article